| Management target | Revenue 21.7% FY27 |
|---|
| Revenue growth | 25.7% YoY in FY26 |
|---|---|
| Margins | Targeting 11–13% PAT margin from current 8–9% |
| Order book | ₹900+ Cr confirmed orders as of March 2026 |
| Demand visibility | Strong; robust enquiry pipeline and structural growth |
| Management confidence | High; visibility through ₹900+ Cr order book |
Growth
FY26 standalone revenue grew 25.7% YoY to ₹410.77 Cr; Operational Profit rose 17% YoY to ₹36.60 Cr.
Outlook
FY27 target: ₹500 Cr revenue and ₹45 Cr PAT. Aiming for 11–13% PAT margin via localization and sourcing.
Risks
Near-term conflict impacts delivery schedules and input costs; freight volatility and geopolitical disruptions noted.
Last quarter's promises, checked
Delivered
- Guided 25% growth → delivered 28.4% YoY revenue growth (= BEAT)
- Guided ₹230 Cr equity infusion → delivered ₹230 Cr via IPO (= BEAT)
- Guided positive cash flow → delivered ₹50 lakhs CFO from -₹36 Cr (= BEAT)
Partly delivered
- Guided debt reduction → delivered ₹42 Cr from ₹54 Cr (= PARTIAL)
Missed
- Guided ₹46.45 Cr net profit → delivered ₹38.36 Cr (= MISS)
Earnings Call filed with BSE, NSE: FABTECH. Summary written with AI assistance from the document.
Fabtech Technologies Ltd: key numbers
- Share price
- ₹145.83
- Market cap
- ₹648.2 Cr
- Revenue (annual)
- ₹410.8 Cr
- Net profit (annual)
- ₹38.36 Cr
- P/E (TTM)
- 13.3×Sector 41.4×
- Promoter holding
- 68.94%+0.00% QoQ
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fabtech Technologies Ltd
All →Fabtech Technologies Merger & Restructuring
Fabtech Technologies Limited is incorporating a new step-down subsidiary in Egypt through its subsidiary Fabtech Technologies LLC. The entity will focus on turnkey pharma projects and HVAC activities.
Fabtech Technologies Management Change
Ms. Neetu Aditya Tibrewal resigned as Company Secretary and Compliance Officer of Fabtech Technologies, effective 24 Sep 2026. She cited pursuit of professional opportunities outside the company.
Fabtech Technologies Bags ₹21 Cr Order from Meril Innovations LLC
Fabtech Technologies won a ₹21 Crore turnkey pharmaceutical manufacturing project from Meril Innovations LLC. Execution is expected within 20-24 weeks on an FOB basis.
- Value
- ₹21.00 Cr
- From
- Meril Innovations LLC
- Execution
- 20-24 weeks
Fabtech Technologies Business Update
Fabtech's subsidiary completed a 14,000 sqm turnkey cleanroom facility for Himalaya Wellness Company in UAE within a year. No contract value disclosed.
- turnkey cleanroom facility area
- 14000 sqm
Fabtech Technologies Investor Presentation: Key Takeaways
Fabtech turned profitable in Q1 FY27, reporting revenue of ₹74.98 Cr and PAT of ₹4.21 Cr. Strategy shifts toward high-margin Saudi and African EPC markets.
- Call
- Guides 25% growth
Fabtech Technologies Earnings Call Transcript: Key Takeaways
Fabtech turned profitable this quarter, driven by a strategic pivot toward high-margin international projects in Saudi Arabia and Africa, despite geopolitical headwinds in the UAE.
- Call
- Guides 25% growth